0001662119-22-000002.txt : 20220706
0001662119-22-000002.hdr.sgml : 20220706
20220706161606
ACCESSION NUMBER: 0001662119-22-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220705
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amado Rafael
CENTRAL INDEX KEY: 0001662119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 221068889
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-07-05
0
0001737287
Allogene Therapeutics, Inc.
ALLO
0001662119
Amado Rafael
210 EAST GRAND AVE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP of R&D and CMO
Common Stock
2022-07-05
4
S
0
2000
11.44
D
542257
D
1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022.
Veer Bhavnagri as attorney-in-fact for Rafael Amado
2022-07-06